CytoMed Therapeutics (GDTC) Stock Chart & Stock Price History $2.18 -0.02 (-1.09%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$2.19 +0.02 (+0.87%) As of 07/11/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsSEC FilingsShort InterestTrendsBuy This Stock CytoMed Therapeutics Stock Price Performance The CytoMed Therapeutics (GDTC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 7.19%, with a year-to-date return of -36.00%. In the past month, the stock has increased 2.54%, reflecting recent market activity. As of the latest close, CytoMed Therapeutics traded at $2.18 with a market cap of and volume of 1,505 shares. Receive GDTC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytoMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.29%1 Month Performance+2.54%3 Month Performance-10.45%Year-To-Date Performance-36.00%1 Year Performance+7.19% GDTC Stock Chart for Monday, July, 14, 2025 GDTC Chart by TradingView CytoMed Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$2.20$2.18-1.09%$2.21$2.211,505 shs$0.0007/10/2025$2.25$2.20-2.22%$2.35$2.1613,140 shs$0.0007/09/2025$2.31$2.25-2.60%$2.27$2.097,280 shs$24.62 million07/08/2025$2.15$2.31+7.44%$2.31$2.185,070 shs$0.0007/07/2025$2.10$2.15+2.38%$2.21$2.089,249 shs$0.0007/04/2025$2.10$2.10$2.20$2.20862 shs$0.0007/03/2025$2.11$2.10-0.24%$2.20$2.20862 shs$0.0007/02/2025$2.12$2.11-0.47%$2.12$2.082,720 shs$0.0007/01/2025$2.25$2.12-6.00%$2.25$2.0715,693 shs$0.0006/30/2025$2.28$2.25-1.32%$2.32$2.193,560 shs$24.62 million Get the Latest News and Ratings for GDTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$2.28$2.28+0.22%$2.34$2.33271 shs$0.0006/26/2025$2.32$2.28-1.94%$2.32$2.257,557 shs$0.0006/25/2025$2.29$2.32+1.31%$2.35$2.253,156 shs$0.0006/24/2025$2.23$2.29+2.92%$2.34$2.271,616 shs$0.0006/23/2025$2.25$2.23-1.07%$2.35$2.182,610 shs$0.0006/20/2025$2.24$2.25+0.36%$2.31$2.151,420 shs$0.0006/19/2025$2.24$2.24$2.33$2.1042,867 shs$0.0006/18/2025$2.16$2.24+3.75%$2.33$2.1042,867 shs$0.0006/17/2025$2.09$2.16+3.35%$2.10$2.101,506 shs$23.63 million06/16/2025$2.12$2.09-1.51%$2.09$2.045,887 shs$22.87 million06/13/2025$2.13$2.12-0.38%$2.08$2.08677 shs$23.22 million Related Companies ATNFW Stock Chart LBPSW Stock Chart AEHAW Stock Chart AIMDW Stock Chart ALVOW Stock Chart AMPE Stock Chart ARAV Stock Chart ACABW Stock Chart BFRIW Stock Chart BTMDW Stock Chart Receive GDTC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytoMed Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GDTC) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoMed Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CytoMed Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
